IQV IQVIA Inc.: Company Short-Term Debts

Brandmark of IQVIA (IQV)

The status of the global clinical data ecosystem of IQVIA Holdings Inc. (IQV) ensures leadership in drug launches, which confirms the scale of short-term liabilities. The value of 1.28 serves as a current indicator of this trend. The business relies on external laboratories for testing while simultaneously implementing cloud automation for regulatory reporting, which optimizes internal processes and reduces the company's operational risks.

IQVIA Holdings (IQV) - Company Short-Term Loans and Borrowings from 07/04/2022 to 11/01/2026

Analytical breakdowns and data insights for company Quintiles (IQV)

- current quotes and average value forecast:
Price Chart IQVIA|IQV - Consensus Target
- company stock capitalization data:
Market Capitalization IQVIA Holdings|IQV - Enterprise Value
- business book valuation details:
Accounting Value per Share IQVIA|IQV - Accounting Value of Company|Market Cap to Net Assets Ratio iqvia.com|IQV - Aggregate Business Assets
- debt level and financial liquidity data:
Total Debt to Capital IQVIA Holdings Inc.|IQV - Long-Term Liabilities to Capital|Short-Term Debt to Equity IQVIA Holdings Inc.|IQV - Company Total Debt Obligations|Debt to Book Value IQVIA Holdings|IQV - Amount of Long-Term Liabilities|Company Short-Term Debt IQVIA|Quick Ratio iqvia.com
- earnings and valuation multiples indicators:
IQV - Net Financial Result
Fundamental company analysis:IQVIA - IQV
Manufactured products of IQVIA Holdings Inc.

IQVIA Holdings Inc. (IQV) strategic alliances in biotechnology and IT require precise financial planning, as reflected by the trajectory of its short-term debt. This indicator captures the aggregate of all obligations with a maturity horizon of up to one year. The metric measures the current debt load, allowing for an assessment of solvency risk. A reduction in loan volume indicates strengthening liquidity, serving as a marker of capital stability for investors during the scaling of clinical trials.

Who IQVIA Holdings Inc. competes with

LH - Company Short-Term Debt|Medpace Holdings (MEDP) - Company Current Liabilities|ICLR: Company Short-Term Debts|Charles River Corp (CRL) - Company Short-Term Debts|Company Current Liabilities EVO|FTRE: Company Short-Term Loans and Borrowings|Company Current Liabilities LFCR (Lifecore Biomedical)|Amount of Current Liabilities OABI|Company Short-Term Debts NOTV (Inotiv Corp)|Avid Bioservices Inc (CDMO) - Short-Term Debt|CTLT - Company Short-Term Debt|Short-Term Debt Volume nighthawkbio.com SCPX